Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet transfusion trigger in difficult patients.

P Rebulla1

  • 1Centro Trasfusionale e di Immunologia dei Trapianti, IFCCS Ospedale Maggiore, Milan, Italy. prebulla@libero.it

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|August 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes.

Journal of cellular physiology·2014
Same author

Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care.

Vox sanguinis·2014
Same author

Should DEHP be eliminated in blood bags?

Vox sanguinis·2013
Same author

The use of the electronic (computer) cross-match.

Vox sanguinis·2013
Same author

Donor selection and release criteria of cellular therapy products.

Vox sanguinis·2012
Same author

Prophylactic platelet transfusions.

Vox sanguinis·2012
Same journal

Catastrophic CD34+ autologous hematopoietic stem cell collection despite sustained mobilization and solutions to rescue the harvests.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Title of the study: Corrected Count Increment as a Predictor of Early Graft Dysfunction and Mortality Following Living Donor Liver Transplantation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

TLR4/MD-2 complex promotes transfusion-related acute lung injury pathogenesis through the activation of the AP-1 and NF-κB signaling pathways.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

The Strategic Utility of Cryopreserved Platelets in Outer Space.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Genotyping of Human Neutrophil Antigen-3 by High Resolution Melting Analysis in Southern Thai Blood Donors.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Transfusion rate and risk factors in hemiarthroplasty of hip: A nationwide cohort study.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
See all related articles

Platelet transfusion guidelines recommend lower pre-transfusion triggers for oncohematological patients and specific perioperative procedures. These evidence-based recommendations ensure patient safety and optimize resource use in various clinical scenarios.

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Oncohematology

Background:

  • Established guidelines for platelet transfusion triggers exist, with historical variations in recommended levels.
  • Previous guidelines, including those from NIH and ASCO, have addressed platelet transfusion thresholds.
  • Consensus on optimal platelet triggers is generally strong for stable patients but varies for complex cases.

Purpose of the Study:

  • To review and consolidate current consensus on platelet transfusion triggers across diverse clinical settings.
  • To provide evidence-based recommendations for platelet transfusion thresholds in oncohematological and surgical patients.
  • To highlight the importance of clinical evaluation and platelet count accuracy in transfusion decisions.

Main Methods:

  • Literature review of existing guidelines and proposed triggers for platelet transfusion.

Related Experiment Videos

  • Synthesis of consensus recommendations from multiple professional organizations.
  • Compilation of specific platelet count triggers for various medical and surgical procedures.

    • Main Results:

    • A prophylactic pre-transfusion trigger of 10,000 platelets/microL is considered safe for stable oncohematological patients.
    • Perioperative triggers of 50,000/microL for general surgery and 100,000/microL for neurosurgery are adequate.
    • Specific triggers are proposed for conditions like disseminated intravascular coagulation, invasive procedures, and neonatal cases.

    Conclusions:

    • Current evidence supports lower platelet transfusion triggers in specific patient populations and procedures.
    • Individualized clinical assessment remains crucial, alongside awareness of platelet counter limitations.
    • Ensuring prompt availability of quality platelet products is essential for managing thrombocytopenic patients.